JATT II Acquisition Corp IPO
Analysis based on 6 articles · First reported Apr 16, 2026 · Last updated Apr 20, 2026
The successful IPO of BHAV Acquisition Corp provides a new investment opportunity in the SPAC market, particularly for investors interested in healthcare and biotechnology. The capital raised will enable BHAV Acquisition Corp to pursue business combinations, potentially leading to new public companies in these sectors.
BHAV Acquisition Corp, a newly formed special purpose acquisition company (SPAC), successfully closed its initial public offering (IPO) on April 20, 2026, raising $60,000,000 by offering 6,000,000 ordinary shares at $10.00 each. The shares began trading on the Nasdaq Global Market under the ticker symbol 'JATT' on April 17, 2026. Guggenheim Partners served as the sole book-running manager for the offering. The United States — United States Securities and Exchange Commission declared the registration statement effective on April 16, 2026. BHAV Acquisition Corp, sponsored by JATT Ventures II L.P. and led by Someit Sidhu and Nicholas Fernandez, intends to focus its search for a business combination target on healthcare and healthcare-related businesses, with an emphasis on biotechnology and life sciences.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard